COMPARE · Data as of August 21, 2026
HQY vs PRVA
Verdict: Side-by-side breakdown using the Bull Rankings model. HQY scored 66.5, PRVA scored 56.3 — HQY leads.
Compare another set
HQY
HealthEquity, Inc.
66.5
$105.41 · $8.8B
fundamentals as of
Score gap
10.2
HQY leads
PRVA
Privia Health Group, Inc.
56.3
$21.12 · $2.7B
fundamentals as of
At a glance · who leads each dimension, on the model's own rules
- CheapestHQY39.5x
- Fastest growthPRVA+24.1%
- Strongest balance sheetPRVA0.01
- Highest qualityHQY71 / 100
- Largest discount to fair valuePRVA-14%
Side by side · every name on one set of axes
Growth against the P/E multiple. Up and to the right is cheaper and faster — the quality-growth idea in one picture. Points beyond the axis are pinned to the edge and marked off-scale rather than allowed to compress everything else.
The model, pillar by pillar (0–100 each)
HQY
stronger →← stronger
PRVA
71
Qualityreturns · margins · balance sheet
45
62
Growthrevenue & earnings expansion
91
67
Valuevaluation vs sector peers
44
HQY is stronger on 2 of 3 pillars.
Fundamentals, head-to-head
HQY
PRVA
$488mC
FCF
$131mC
+7.6%B
Rev
+24.1%A-
0.48B
D/E
0.01A
39.5xC+
P/E
96.0xD
1.35B
PEG
4.50D
Winner per row is the stronger grade; where grades tie, the better figure breaks it. A true tie or a missing value shows no highlight.
Valuation · DCF cross-check
HQY
PRVA
6% below
Price vs fair valuelower is cheaper
14% below
~8%/yr
Growth the price implies10-yr FCF · lower = less priced in
~9%/yr
-9%
1-yr DCF upside
-8%
+7%
5-yr DCF upside
+16%
+34%
10-yr DCF upside
+63%
The DCF is a cross-check on intrinsic value, separate from the quality-growth score above.
Model signals
HQY
Why this score
- Buying back stock
PRVA
Why this score
- Diluting shareholders
The companies
HQYHealthEquity, Inc.
Why now
Health Information Services · market cap $8.8b. Trading near 52-week high of $107.62 — momentum setup, limited technical margin of safety. 15 sell-side analysts rate this a Strong Buy with a mean 1-yr target of $118.53 (implying +12% upside).
Moat
Net margin 17% beats the market median by a meaningful margin — the company is keeping more of every revenue dollar than the average S&P constituent. ROE 11% meets the long-run market sustainable threshold — solid but not differentiated; the durability comes from elsewhere. Free cash flow runs well ahead of reported net income — non-cash charges (depreciation, intangible amortization) are holding down GAAP earnings while cash generation stays strong.
Risk
Trading within 2% of the 52-week high — limited technical margin of safety; a momentum reversal would test conviction. Trailing P/E 39x sits well above the S&P median (~20x) — multiple compression is a real risk if revenue growth decelerates.
PRVAPrivia Health Group, Inc.
Why now
Health Information Services · market cap $2.7b. Down 27% from 52-week high of $28.82 — deep drawdown territory. Revenue growing +24%, comfortably above the S&P median. 18 sell-side analysts rate this a Strong Buy with a mean 1-yr target of $31.67 (implying +50% upside).
Moat
Free cash flow runs well ahead of reported net income — non-cash charges (depreciation, intangible amortization) are holding down GAAP earnings while cash generation stays strong.
Risk
Trailing P/E 96.0x prices in sustained high growth — any quarter that disappoints triggers sharp re-rating. Net margin 1.2% is thin — operating leverage cuts both ways; input-cost inflation or pricing pressure hits the bottom line first. ROE 4% is below the long-run sustainable threshold of ~10% — capital efficiency would need to improve for the equity base to compound at the market rate.
Verdict — model-derived comparison
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.
Where HQY and PRVA diverge
On the headline score the gap is 10.2 points in favor of HQY. They get there differently, though — each leads on a different pillar, so the better pick depends on which you weight.
- GrowthHQY 62.3 · PRVA 91.1PRVA +28.8
- QualityHQY 70.6 · PRVA 44.6HQY +26.0
- ValueHQY 66.9 · PRVA 44.0HQY +22.9
Pillars run 0–100 against sector peers, so a score is a statement about a company relative to its own industry rather than to the other name here. A wide Value gap usually means the market already prices the difference in quality or growth — which is the trade-off this comparison comes down to.